Work

A randomized phase II trial of preoperative docetaxel (D) and capecitabine (C) given sequentially or concurrently for Her2 negative breast cancers.

Year: 2009

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs-5122

Authors: S Harichand-Herdt, A Zelnak, T Styblo, M Rizzo, S Gabram, H Bumpers, C D'Orsi, K Carlson, D Senior-Crosby, N Sellers, T Pierce, D Hicklin, J Srinivasiah, F Schnell, R Hermann, R O'Regan

Institutions: Emory University, Morehouse College

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2050028147

Cites:

Cited by:

Related to: 10